Cargando…

Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes

BACKGROUND: Attempts to characterize cardiac structure in heart failure with preserved ejection fraction (HFpEF) in people with type 2 diabetes (T2D) have yielded inconsistent findings. We aimed to determine whether patients with HFpEF and T2D have a distinct pattern of cardiac remodelling compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulsin, Gaurav S., Kanagala, Prathap, Chan, Daniel C. S., Cheng, Adrian S. H., Athithan, Lavanya, Graham-Brown, Matthew P. M., Singh, Anvesha, Yang, Jing, Li, Zhuyin, Khunti, Kamlesh, Davies, Melanie J., Arnold, Jayanth R., Squire, Iain B., Ng, Leong L., McCann, Gerry P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613057/
https://www.ncbi.nlm.nih.gov/pubmed/31308926
http://dx.doi.org/10.1177/2042018819861593
_version_ 1783432991569084416
author Gulsin, Gaurav S.
Kanagala, Prathap
Chan, Daniel C. S.
Cheng, Adrian S. H.
Athithan, Lavanya
Graham-Brown, Matthew P. M.
Singh, Anvesha
Yang, Jing
Li, Zhuyin
Khunti, Kamlesh
Davies, Melanie J.
Arnold, Jayanth R.
Squire, Iain B.
Ng, Leong L.
McCann, Gerry P.
author_facet Gulsin, Gaurav S.
Kanagala, Prathap
Chan, Daniel C. S.
Cheng, Adrian S. H.
Athithan, Lavanya
Graham-Brown, Matthew P. M.
Singh, Anvesha
Yang, Jing
Li, Zhuyin
Khunti, Kamlesh
Davies, Melanie J.
Arnold, Jayanth R.
Squire, Iain B.
Ng, Leong L.
McCann, Gerry P.
author_sort Gulsin, Gaurav S.
collection PubMed
description BACKGROUND: Attempts to characterize cardiac structure in heart failure with preserved ejection fraction (HFpEF) in people with type 2 diabetes (T2D) have yielded inconsistent findings. We aimed to determine whether patients with HFpEF and T2D have a distinct pattern of cardiac remodelling compared with those without diabetes and whether remodelling was related to circulating markers of inflammation and fibrosis and clinical outcomes. METHODS: We recruited 140 patients with HFpEF (75 with T2D and 65 without). Participants underwent comprehensive cardiovascular phenotyping, including echocardiography, cardiac magnetic resonance imaging and plasma biomarker profiling. RESULTS: Patients with T2D were younger (age 70 ± 9 versus 75 ± 9y, p = 0.002), with evidence of more left ventricular (LV) concentric remodelling (LV mass/volume ratio 0.72 ± 0.15 versus 0.62 ± 0.16, p = 0.024) and smaller indexed left atrial (LA) volumes (maximal LA volume index 48 ± 20 versus 59 ± 29 ml/m(2), p = 0.004) than those without diabetes. Plasma biomarkers of inflammation and extracellular matrix remodelling were elevated in those with T2D. Overall, there were 45 hospitalizations for HF and 22 deaths over a median follow-up period of 47 months [interquartile range (IQR) 38–54]. There was no difference in the primary composite endpoint of hospitalization for HF and mortality between groups. On multivariable Cox regression analysis, age, prior HF hospitalization, history of pulmonary disease and LV mass/volume were independent predictors of the primary endpoint. CONCLUSIONS: Patients with HFpEF and T2D have increased concentric LV remodelling, smaller LA volumes and evidence of increased systemic inflammation compared with those without diabetes. This suggests the underlying pathophysiology for the development of HFpEF is different in patients with and without T2D. CLINICALTRIALS.GOV IDENTIFIER: NCT03050593.
format Online
Article
Text
id pubmed-6613057
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-66130572019-07-15 Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes Gulsin, Gaurav S. Kanagala, Prathap Chan, Daniel C. S. Cheng, Adrian S. H. Athithan, Lavanya Graham-Brown, Matthew P. M. Singh, Anvesha Yang, Jing Li, Zhuyin Khunti, Kamlesh Davies, Melanie J. Arnold, Jayanth R. Squire, Iain B. Ng, Leong L. McCann, Gerry P. Ther Adv Endocrinol Metab Cardiovascular Disease and Diabetes: Risk Factors, Prevention and Management BACKGROUND: Attempts to characterize cardiac structure in heart failure with preserved ejection fraction (HFpEF) in people with type 2 diabetes (T2D) have yielded inconsistent findings. We aimed to determine whether patients with HFpEF and T2D have a distinct pattern of cardiac remodelling compared with those without diabetes and whether remodelling was related to circulating markers of inflammation and fibrosis and clinical outcomes. METHODS: We recruited 140 patients with HFpEF (75 with T2D and 65 without). Participants underwent comprehensive cardiovascular phenotyping, including echocardiography, cardiac magnetic resonance imaging and plasma biomarker profiling. RESULTS: Patients with T2D were younger (age 70 ± 9 versus 75 ± 9y, p = 0.002), with evidence of more left ventricular (LV) concentric remodelling (LV mass/volume ratio 0.72 ± 0.15 versus 0.62 ± 0.16, p = 0.024) and smaller indexed left atrial (LA) volumes (maximal LA volume index 48 ± 20 versus 59 ± 29 ml/m(2), p = 0.004) than those without diabetes. Plasma biomarkers of inflammation and extracellular matrix remodelling were elevated in those with T2D. Overall, there were 45 hospitalizations for HF and 22 deaths over a median follow-up period of 47 months [interquartile range (IQR) 38–54]. There was no difference in the primary composite endpoint of hospitalization for HF and mortality between groups. On multivariable Cox regression analysis, age, prior HF hospitalization, history of pulmonary disease and LV mass/volume were independent predictors of the primary endpoint. CONCLUSIONS: Patients with HFpEF and T2D have increased concentric LV remodelling, smaller LA volumes and evidence of increased systemic inflammation compared with those without diabetes. This suggests the underlying pathophysiology for the development of HFpEF is different in patients with and without T2D. CLINICALTRIALS.GOV IDENTIFIER: NCT03050593. SAGE Publications 2019-07-05 /pmc/articles/PMC6613057/ /pubmed/31308926 http://dx.doi.org/10.1177/2042018819861593 Text en © The Author(s), 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Cardiovascular Disease and Diabetes: Risk Factors, Prevention and Management
Gulsin, Gaurav S.
Kanagala, Prathap
Chan, Daniel C. S.
Cheng, Adrian S. H.
Athithan, Lavanya
Graham-Brown, Matthew P. M.
Singh, Anvesha
Yang, Jing
Li, Zhuyin
Khunti, Kamlesh
Davies, Melanie J.
Arnold, Jayanth R.
Squire, Iain B.
Ng, Leong L.
McCann, Gerry P.
Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
title Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
title_full Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
title_fullStr Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
title_full_unstemmed Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
title_short Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
title_sort differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
topic Cardiovascular Disease and Diabetes: Risk Factors, Prevention and Management
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613057/
https://www.ncbi.nlm.nih.gov/pubmed/31308926
http://dx.doi.org/10.1177/2042018819861593
work_keys_str_mv AT gulsingauravs differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT kanagalaprathap differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT chandanielcs differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT chengadriansh differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT athithanlavanya differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT grahambrownmatthewpm differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT singhanvesha differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT yangjing differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT lizhuyin differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT khuntikamlesh differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT daviesmelaniej differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT arnoldjayanthr differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT squireiainb differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT ngleongl differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes
AT mccanngerryp differentialleftventricularandleftatrialremodellinginheartfailurewithpreservedejectionfractionpatientswithandwithoutdiabetes